Shocking the brain back to life: VR and zaps may restore arm movement after stroke
NCT ID NCT04291573
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested whether combining a gentle brain stimulation technique (HD-tDCS) with virtual reality therapy could help people who had a stroke more than three months ago recover arm function. Fifty-eight participants received either real or sham stimulation during VR sessions. The goal was to see if the combo boosts neuroplasticity and improves arm movement, dexterity, and daily use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HD-tDCS (brain stimulation device) and virtual reality therapy
What this could lead to
If it works, this approach could offer a new way to improve arm movement and daily function for people who have had a stroke.
What could go wrong
This was a small, early-stage trial (58 people) with no phase designation, so results may not apply widely. The improvements might be modest and not last long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC POST STROKE INDIVIDUALS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montpellier hospital Lapeyronie
Montpellier, 34000, France